SLPI and cancer: Serpin peptidase inhibitor clade E member 2 (SERPINE2/protease nexin-1) and secretory leukocyte protease inhibitor (SLPI) are secreted serine protease inhibitors which are overexpressed in a number of cancers and involved in tumor formation [5–7].